Available Clinical Trials
Displaying All Clinical Trials (51)
A011401
Randomized Phase III Trial Evaluating the Role of Weight Loss …
Randomized Phase III Trial Evaluating the Role of Weight Loss …
A011502
Alliance A11502 - Aspirin in Preventing Recurrence of Cancer in Patients …
Alliance A11502 - Aspirin in Preventing Recurrence of Cancer in Patients …
A021502
Alliance A021502 - Randomized Trial of Standard Chemotherapy Alone or …
Alliance A021502 - Randomized Trial of Standard Chemotherapy Alone or …
A031102
A031102 – A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy …
A031102 – A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy …
A031501
A031501 - Phase III randomized “Adjuvant study of MK-3475 (pembrolizumab) …
A031501 - Phase III randomized “Adjuvant study of MK-3475 (pembrolizumab) …
A031704
Alliance A031704 - “PD-inhibitor (Nivolumab) and Ipilimumab followed by nivolumab …
Alliance A031704 - “PD-inhibitor (Nivolumab) and Ipilimumab followed by nivolumab …
A041501
A041501 - A Phase III Trial to Evaluate the Efficacy …
A041501 - A Phase III Trial to Evaluate the Efficacy …
A041701
A041701 - A Randomized Phase II/III Study of Conventional Chemotherapy …
A041701 - A Randomized Phase II/III Study of Conventional Chemotherapy …
A041702
A041702 - A Randomized Phase III Study of Ibrutinib Plus …
A041702 - A Randomized Phase III Study of Ibrutinib Plus …
A051301
A051301 - A randomized double-blind phase III study of ibrutinib …
A051301 - A randomized double-blind phase III study of ibrutinib …
A051701
A051701 - Randomized phase II/III study of venetoclax (ABT 199) …
A051701 - Randomized phase II/III study of venetoclax (ABT 199) …
A081105
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo …
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo …
A151216
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST). …
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST). …
A221505
A221505 - RT CHARM: Phase III Randomized Trial of Hypofractionated …
A221505 - RT CHARM: Phase III Randomized Trial of Hypofractionated …
AGCT1531
AGCT1531: A Phase 3 Study of Active Surveillance for Low …
AGCT1531: A Phase 3 Study of Active Surveillance for Low …
Astex SGI-110-07
A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) …
A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) …
BMS CA209-436
A Phase I/ II Study to Evaluate the Safety and …
A Phase I/ II Study to Evaluate the Safety and …
BMS CA209-592
An Exploratory Study of the Biologic Effects and Biomarkers of …
An Exploratory Study of the Biologic Effects and Biomarkers of …
BMS CA209-812
Randomized, Open-label, Phase 3 Trial of Nivolumab plus Brentuximab Vedotin …
Randomized, Open-label, Phase 3 Trial of Nivolumab plus Brentuximab Vedotin …
BMS CA209-914
A Phase 3 Randomized Study Comparing Nivolumab and Ipilimumab Combination …
A Phase 3 Randomized Study Comparing Nivolumab and Ipilimumab Combination …
CALGB 30610
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with …
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with …
Cancer Insight – Melanoma Vaccine
A prospective, randomized, blinded, placebo-controlled, phase IIb trial of an …
A prospective, randomized, blinded, placebo-controlled, phase IIb trial of an …
CCTG MA.39
Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer …
Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer …
CerRx FEN-T14
Phase II Trial of Intravenous Fenretinide (N-(4-hydroxyphenyl) retinamide, 4-HPR) Emulsion …
Phase II Trial of Intravenous Fenretinide (N-(4-hydroxyphenyl) retinamide, 4-HPR) Emulsion …
E4512
A Phase III Double-Blind Trial for Surgically Resected Early Stage …
A Phase III Double-Blind Trial for Surgically Resected Early Stage …
EA1131
Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. …
Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. …
EA3161
EA3161 - A Phase II/III Randomized Study of Maintenance Nivolumab …
EA3161 - A Phase II/III Randomized Study of Maintenance Nivolumab …
EA4151
EA4151 - A Randomized Phase III Trial of Consolidation with …
EA4151 - A Randomized Phase III Trial of Consolidation with …
EA6134
EA6134 - A Randomized Phase III Trial of Dabrafenib + …
EA6134 - A Randomized Phase III Trial of Dabrafenib + …
EA8143
EA8143 – A Phase 3 RandOmized Study Comparing PERioperative Nivolumab …
EA8143 – A Phase 3 RandOmized Study Comparing PERioperative Nivolumab …
EA9131
EA9131 - A Simplified Patient Care Strategy to Decrease Early …
EA9131 - A Simplified Patient Care Strategy to Decrease Early …
EA9161
EA9161 - A Randomized Phase III Study of the Addition …
EA9161 - A Randomized Phase III Study of the Addition …
EAQ162CD
EAQ162CD - Longitudinal Assessment of Financial Burden in Patients with …
EAQ162CD - Longitudinal Assessment of Financial Burden in Patients with …
GOG 0263
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation …
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation …
Methylgene 516-001
A Phase 1/1b Study of MGCD516 in Patients With Advanced …
A Phase 1/1b Study of MGCD516 in Patients With Advanced …
MK-3475-170
A Phase II Study of Pembrolizumab (MK-3475) in Subjects with …
A Phase II Study of Pembrolizumab (MK-3475) in Subjects with …
NHLBI-MDS
The National Myelodysplastic Syndromes (MDS) Study
The National Myelodysplastic Syndromes (MDS) Study
NRG BR003
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin …
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin …
NRG GY005
NRG GY005 - A Randomized Phase II/III study of the …
NRG GY005 - A Randomized Phase II/III study of the …
NRG-CC004
NRG-CC004 - Phase II Double Blind Dose Finding Trial of …
NRG-CC004 - Phase II Double Blind Dose Finding Trial of …
NRG-GU002
NRG-GU002 - Phase II-III Trial Of Adjuvant Radiotherapy and Androgen …
NRG-GU002 - Phase II-III Trial Of Adjuvant Radiotherapy and Androgen …
NRG-GU007
NRG-GU007, Randomized Phase II Trial of Niraparib with Standard Combination …
NRG-GU007, Randomized Phase II Trial of Niraparib with Standard Combination …
NRG-GY018
NRG-GY018 - A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab …
NRG-GY018 - A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab …
NRG-LU002
NRG-LU002 - Maintenance Systemic Therapy versus Consolidative Stereotactic Body Radiation …
NRG-LU002 - Maintenance Systemic Therapy versus Consolidative Stereotactic Body Radiation …
NSABP B-51
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and …
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and …
S1418
SWOG S1418 - A Randomized, Phase III Trial to Evaluate …
SWOG S1418 - A Randomized, Phase III Trial to Evaluate …
S1616
S1616 - A Phase II Randomized Study of Nivolumab (NSC-748726) …
S1616 - A Phase II Randomized Study of Nivolumab (NSC-748726) …
S1801
S1801 - A Phase II Randomized Study of Adjuvant Versus …
S1801 - A Phase II Randomized Study of Adjuvant Versus …
S1815
S1815 - A Phase III Randomized Trial of Gemcitabine, Cisplatin, …
S1815 - A Phase III Randomized Trial of Gemcitabine, Cisplatin, …
SWOG S1714
S1714 - A Prospective Observational Cohort Study to Develop a …
S1714 - A Prospective Observational Cohort Study to Develop a …
SWOG S1826
S1826 - A Phase III, Randomized Study of Nivolumab (Opdivo) …
S1826 - A Phase III, Randomized Study of Nivolumab (Opdivo) …
Appointments Available
Request an appointment
Schedule Now
Information Hotline
Have a question? Call us at:
(864) 603-6200
